EUVIMEDEUVIMED entdecken
Open Access

Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors

Ivone Gomes, Achla Gupta, Elyssa B Margolis, Lloyd D Fricker, Lakshmi A Devi iD

Molecular Pharmacology · 2024-11 · 106 (5) · 240-252

DOI: 10.1124/molpharm.124.000947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2024-11. Verfasst von Ivone Gomes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pharmacological Sciences (I.G., A.G., L.A.D.) and Psychiatry (L.A.D.), and Nash Family Department of Neuroscience (L.A.D.), Icahn Scho…. Hauptthemen laut MEDLINE: Ketamine, Receptors, Opioid. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ketamine is a glutamate receptor antagonist that was developed over 50 years ago as an anesthetic agent. At subanesthetic doses, ketamine and some metabolites are analgesics and fast-acting antidepressants, presumably through targets other than glutamate receptors. We tested ketamine and its metabolites for activity as allosteric modulators of opioid receptors expressed as recombinant receptors in heterologous systems and with native receptors in rodent brain; signaling was examined by measuring GTP binding, β-arrestin recruitment, MAPK activation, and neurotransmitter release. Although micromolar concentrations of ketamine alone had weak agonist activity at μ opioid receptors, the combination of submicromolar concentrations of ketamine with endogenous opioid peptides produced robust synergistic responses with statistically significant increases in efficacies. All three opioid receptors (μ, δ, and κ) showed synergism with submicromolar concentrations of ketamine and either methionine-enkephalin (Met-enk), leucine-enkephalin (Leu-enk), and/or dynorphin A17 (Dyn A17), albeit the extent of synergy was variable between receptors and peptides. S-ketamine exhibited higher modulatory effects compared with R-ketamine or racemic ketamine, with ∼100% increase in efficacy. Importantly, the ketamine metabolite 6-hydroxynorketamine showed robust allosteric modulatory activity at μ opioid receptors; this metabolite is known to have analgesic and antidepressant activity but does not bind to glutamate receptors. Ketamine enhanced potency and efficacy of Met-enkephalin signaling both in mouse midbrain membranes and in rat ventral tegmental area neurons as determined by electrophysiology recordings in brain slices. Taken together, these findings support the hypothesis that some of the therapeutic effects of ketamine and its metabolites are mediated by directly engaging the endogenous opioid system. SIGNIFICANCE STATEMENT: This study found that ketamine and its major biologically active metabolites function as potent allosteric modulators of μ, δ, and κ opioid receptors, with submicromolar concentrations of these compounds synergizing with endogenous opioid peptides, such as enkephalin and dynorphin. This allosteric activity may contribute to ketamine's therapeutic effectiveness for treating acute and chronic pain and as a fast-acting antidepressant drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineReceptors, OpioidAnimalsAllosteric RegulationHumansMiceRatsMaleRats, Sprague-DawleyHEK293 CellsCricetulusCHO Cells

Substanzen

KetamineReceptors, Opioid

Autor:innen und Institutionen

  • Departments of Pharmacological Sciences (I.G., A.G., L.A.D.) and Psychiatry (L.A.D.), and Nash Family Department of Neuroscience (L.A.D.), Icahn School of Medicine at Mount Sinai, New York, New York; UCSF Weill Institut…

ORCID-Profile: Lakshmi A Devi

Förderung

  • NIDA NIH HHS
  • NIAAA NIH HHS

Zitieren

APA

Gomes, I., Gupta, A., Margolis, E. B., Fricker, L. D., & Devi, L. A. (2024). Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors. Molecular Pharmacology, 106(5), 240-252. https://doi.org/10.1124/molpharm.124.000947

Vancouver

Gomes I, Gupta A, Margolis EB, Fricker LD, Devi LA. Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors. Molecular Pharmacology. 2024;106(5):240-252. doi:10.1124/molpharm.124.000947

BibTeX
@article{Gomes2024,
  author = {Gomes, Ivone and Gupta, Achla and Margolis, Elyssa B and Fricker, Lloyd D and Devi, Lakshmi A},
  title = {Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid Receptors},
  journal = {Molecular Pharmacology},
  year = {2024},
  volume = {106},
  number = {5},
  pages = {240--252},
  doi = {10.1124/molpharm.124.000947}
}
Kostenlos starten →